A REVIEW OF MBL77

mutations provided The point that, as discussed below, CLL therapy relies to the existence or absence of these mutations. The existing consensus is the fact that, in addition to clonal mutations, subclonal mutations using a variant allelic frequency starting from five to 10% (and so underneath the brink of detection by common molecular tactics) may